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Linear ubiquitination is crucial for innate and adap-
tive immunity. The linear ubiquitin chain assembly
complex (LUBAC), consisting of HOIL-1, HOIP, and
SHARPIN, is the only known ubiquitin ligase that gen-
erates linear ubiquitin linkages. HOIP is the catalyti-
cally active LUBAC component. Here, we show that
both constitutive and Tie2-Cre-driven HOIP deletion
lead to aberrant endothelial cell death, resulting in
defective vascularization and embryonic lethality at
midgestation. Ablation of tumor necrosis factor re-
ceptor 1 (TNFR1) prevents cell death, vascularization
defects, and death at midgestation. HOIP-deficient
cells are more sensitive to death induction by both
tumor necrosis factor (TNF) and lymphotoxin-a
(LT-a), and aberrant complex-II formation is respon-
sible for sensitization to TNFR1-mediated cell death
in the absence of HOIP. Finally, we show that HOIP’s
catalytic activity is necessary for preventing TNF-
induced cell death. Hence, LUBAC and its linear-
ubiquitin-forming activity are required for maintain-
ing vascular integrity during embryogenesis by
preventing TNFR1-mediated endothelial cell death.
INTRODUCTION
Ubiquitination is the covalent attachment of ubiquitin to a target
protein. When ubiquitin itself is the target, interubiquitin linkages
are formed. Eight amino groups within the ubiquitin moiety,
namely the respective ε-amino groups on its seven lysines and
the a-amino group on the amino-terminal methionine (M1), can
serve as acceptor for the terminal carboxyl group of the incoming
ubiquitin. Thereby, eight structurally and functionally distinct diu-
biquitin linkage types can be generated (Komander, 2009). The
ubiquitin linkage resulting from the use of M1 of ubiquitin, theso-called linear ubiquitin linkage, is involved in gene activation
and regulates inflammation and cell death in several innate and
adaptive immune signaling pathways (Iwai et al., 2014; Rieser
et al., 2013; Walczak et al., 2012). The linear ubiquitin chain as-
sembly complex (LUBAC) is currently the only known E3 ligase
that generates linear linkages under physiological conditions
and is composed of three proteins—heme-oxidized iron-respon-
sive element-binding protein 2 (IRP2) ubiquitin ligase-1 (HOIL-1;
also known as RanBP-type andC3HC4-type zinc finger-contain-
ing protein 1 [RBCK1]), HOIL-1 interacting protein (HOIP; also
known as ring finger protein 31 [RNF31]), and SH3 and multiple
ankyrin repeat domains protein (SHANK)-associated RBCK1 ho-
mology (RH)-domain-interacting protein (SHARPIN; also known
as SHANK-interacting protein-like 1 [SIPL1]) (Gerlach et al.,
2011; Ikeda et al., 2011; Tokunaga et al., 2011)—with HOIP being
the catalytically active component of this complex (Tokunaga
et al., 2009).
LUBAC has been identified to regulate various signaling path-
ways that promote canonical NF-kB activation, including the
ones triggered by tumor necrosis factor (TNF), nucleotide oligo-
merization domain 2 (NOD2), interleukin 1 (IL-1), and Toll-like re-
ceptor 2 (TLR2) and TLR4 (Damgaard et al., 2012; Emmerich
et al., 2013; Gerlach et al., 2011; Sasaki et al., 2013; Zak et al.,
2011; Zinngrebe et al., 2014). The best-characterized pathway
involving LUBAC is the one triggered by tumor necrosis factor re-
ceptor 1 (TNFR1) activation. The crucial hub in this pathway is
the TNFR1-signaling complex (TNF-RSC). Upon binding to
TNF, TNFR1 oligomerizes, resulting in recruitment of TRADD,
TRAF2, cIAP1/2, and RIP1. cIAP1/2-mediated ubiquitination of
components of the TNF-RSC leads to recruitment of the TAK1-
TAB1-TAB2 complex for mitogen-activated protein kinase
(MAPK) activation and of LUBAC. LUBAC in turn forms linear
ubiquitin linkages on RIP1 and NEMO/IKKg, stabilizing and acti-
vating the IKKa-IKKb-NEMO/IKKg complex for optimal NF-kB
activation (Gerlach et al., 2011; Schmukle and Walczak, 2012).
Alternatively, when the TNF-RSC is destabilized by inhibition,
absence, or malfunction of its components, a secondary cyto-
plasmic complex, known as complex-II, is formed around RIP1Cell Reports 9, 153–165, October 9, 2014 ª2014 The Authors 153
Figure 1. HOIP Deficiency Results in Embryonic Lethality at Midgestation
(A) Quantification of genotypes of animals obtained after intercrossing Hoip+/ mice. Expected values according to Mendelian frequencies are indicated in
brackets. *Dead.
(B) Time-line of the embryonic development ofHoip+/+,Hoip+/, andHoip/ embryos from E9.5 to E12.5. E9.5Hoip/ embryos appeared normal (i–iii), whereas
E10.5 embryos lacked vascularization in the yolk sac and were smaller compared to wild-type littermates (iv–vi). At E11.5 and E12.5, embryos were dead (vii–ix
and x–xii, respectively). Heterozygosity of Hoip has no detectable aberration. See also Figure S1D.
(C) Vascular defects at E10.5 are shown macroscopically (i–iii) and microscopically by PECAM-1 staining in yolk sacs (iv–vi). Histological analysis revealed heart
defects such as enlargement of the pericardial cavity (black line) and thinning of the ventricular wall (arrow) (vii–ix). See also Figure S1E.
(D) Branching point quantification of images in (C) (iv–vi). Statistics were performed by ANOVA for multiple comparisons. Data are presented asmean ±SEM (n = 3
yolk sacs).
(E) Quantification of the pericardial space was performed on five serial sections of the heart for each embryo. Data are presented asmean ± SEM (n = 3 embryos).involving caspase-8, FADD, cFLIP, and RIP3. This complex in-
duces cell death by apoptosis or necroptosis (Micheau and
Tschopp, 2003; Tenev et al., 2011).
The essential role of LUBAC in TNF signaling was evidenced in
mice lacking SHARPIN (chronic proliferative dermatitis mice
[cpdm]), which develop a spontaneous inflammatory syndrome
(Seymour et al., 2007). We and others previously showed that
cells derived from cpdmmice have decreased NF-kB activation
and are more sensitive to TNF-induced cell death (Gerlach et al.,
2011; Ikeda et al., 2011; Tokunaga et al., 2011). Importantly, we
could further show that deletion of TNF in cpdmmice completely
rescued them from the inflammatory disease (Gerlach et al.,
2011). Together, these results suggested TNF-dependent cell
death as causative for the inflammatory manifestations of the
cpdm phenotype. However, as linear ubiquitination is only sup-
pressed, but not abolished, in the absence of SHARPIN, the
effect of a complete lack in LUBAC activity on physiology is un-
known.We therefore examined the physiological role of the cata-
lytically active LUBAC component, HOIP, by studying mice
deficient for this component. Here, we report that HOIP deletion
leads to embryonic lethality at midgestation due to TNFR1-medi-154 Cell Reports 9, 153–165, October 9, 2014 ª2014 The Authorsated aberrant death of endothelial cells, disrupting the vascular
architecture.
RESULTS
HOIP Deficiency Results in Embryonic Lethality
HOIP-deficient C57BL/6 mice were obtained as described in
Experimental Procedures (Figures S1A and S1B). Among more
than 100 progeny from Hoip heterozygous mouse intercrosses,
not a single mouse with homozygous deletion in the Hoip gene
was born, indicating that HOIP deficiency results in embryonic
lethality (Figure 1A). Western blotting of whole embryos
confirmed HOIP absence and revealed a substantial concomi-
tant decrease in HOIL-1 and SHARPIN expression (Figure S1C),
in line with previous observations in vitro (Gerlach et al., 2011;
Tokunaga et al., 2011).
To define the embryonic stage at which HOIP-deficient
(Hoip/) embryos die, embryos were analyzed at different
days of gestation. No morphological differences among
Hoip+/+, Hoip+/, and Hoip/ embryos were detected at 8 and
9 days of embryonic development (E8.5–E9.5) (Figure S1D;
Figure 2. HOIP Deficiency Leads to Exacer-
bated Cell Death Induction
(A) Representative images of cell death as de-
tected by whole-mount TUNEL staining. In
Hoip/ embryos, cell death was observed mainly
in yolk sacs first appearing at E9.5 (i–iv) and
significantly increasing at E10.5 (v–viii). Images (iii)
and (iv) and (vii) and (viii) are magnifications of the
indicated regions of the yolk sac. See also Figures
S2A and S2E.
(B) Quantification of cell death observed in (A).
Data are presented as mean ± SEM (n = 3 em-
bryos). AU, arbitrary units.
(C) Cleaved caspase-3 and PECAM-1 double
staining in yolk sacs. Merged images show co-
localization of cleaved caspase-3 (green) and
PECAM-1 (red). See also Figure S2F.
(D) Quantification of cleaved-caspase-3-positive
cells. Data are presented as mean ± SEM (n = 3
yolk sacs). See also Figure S2B.Figures 1B i–iii). At E10.5, however, Hoip/ embryos were small
and had aberrant vascularization with only fewmajor vessels de-
tected macroscopically (Figures 1B iv–vi and 1C i–iii). These em-
bryos were resorbed at E11.5/12.5 (Figures 1B vii–ix and x–xii,
respectively). Thus, Hoip/ embryos die at E10.5.
Since absence of proper yolk sac vascularization could cause
embryonic lethality, we examined the yolk sac endothelium in
more detail. Staining of PECAM-1, an endothelial cell marker, re-
vealed severe vascular architectural defects with decreased
vasculardensityasdeterminedbyquantificationof vesselbranch-
ing points (Figures 1C iv–vi and 1D). Histological analysis showed
abnormalities mainly in the embryos’ hearts with enlargement of
the pericardial space (Figures 1C vii–ix and 1E) andmarked atten-
uation of the ventricular wall (Figures 1C vii–ix), features associ-
ated with decreased vascular density in the yolk sac and, hence,
less blood arriving at the heart. At E9.5, yolk sac vascularization
was already affected, albeit mildly, whereas no aberrant pheno-
type was observed in the heart (Figures S1E and S1F). Thus,
althoughdefects start toappearatE9.5, thephenotype ismanifest
at E10.5, and nearly all embryos are dead by E11.5.
Importantly, Hoip is ubiquitously expressed at E10.5 as deter-
mined by in situ hybridization in wild-type embryos (Figure S1G),
indicating that the vascular phenotype is a consequence of HOIP
being required for normal vascularization at this developmental
stage, rather than resulting from specific expression of HOIP in
the vasculature.
Hoip/ Embryos Suffer from Excessive Endothelial Cell
Death at Midgestation
To study the cause of the disrupted vasculature in yolk sacs of
Hoip/ embryos, we analyzed cell death by whole-mount
TUNEL staining. At E8.5, no difference was observed betweenCell Reports 9, 153–165Hoip/ and Hoip+/ embryos (Fig-
ure S2A). However, at E9.5, Hoip/ em-
bryos showed a significant increase in
TUNEL-positive cells (Figures 2A i–iv
and 2B), and by E10.5, this differencewas dramatic, correlating with near-complete disruption of yolk
sac vascular architecture (Figures 2A v–viii and 2B) and
increased cell death in the heart of HOIP-deficient embryos (Fig-
ures S2C and S2D). At E11.5, massive cell death in the yolk sac
and in the embryo proper, particularly in heart and forebrain, was
observed, correlating with resorption (Figure S2E).
Using cleaved caspase-3 as a marker of apoptotic cells, we
found that apoptosis was increased in Hoip/ yolk sacs at
E9.5 (Figure S2B) and that this increase was even more pro-
nounced at E10.5 (Figures 2C and 2D). At E11.5, cleaved cas-
pase-3 was also detected in vessels throughout the embryo
(Figure S2F) correlating with disruption of vascular architecture
and death. As cleaved caspase-3 was present in PECAM-1+
cells (Figure 2C), apoptosis occurred in endothelial cells. These
results suggest that in Hoip/ embryos, excessive apoptosis
of endothelial cells, most likely starting at E9.5 in the yolk sac
and spreading over the next few days of embryonic development
throughout the embryo (note that vascularization in the embryo
proper is affected at E11.5, but not at E10.5; Figure S2F), could
be responsible for vascular defects and, consequently, lethality.
Endothelial Deletion of Hoip Phenocopies Constitutive
Hoip Deletion
To evaluate whether HOIP deficiency in endothelial cells was
indeed responsible for embryonic lethality at E10.5, we aimed
to specifically delete HOIP from endothelial cells by crossing
Hoipfl/fl mice with mice expressing the Cre recombinase under
the control of the endothelium-specific Tie2 promoter (Hoipfl/fl
Tie2-Cre+). We identified only threeHoipfl/flTie2-Cre+ at weaning
compared to an expected 36.5 mice (Figure S3A; Figure 3A),
suggesting that HOIP deficiency in endothelial cells is sufficient
to cause embryonic lethality. It is likely that the three mice that, October 9, 2014 ª2014 The Authors 155
Figure 3. HOIP Deficiency in Endothelium Results in Embryonic Lethality at E10.5
(A) Quantification of genotypes of animals obtained after crossing Hoipfl/wtTie2-Cre+ males with Hoipfl/flTie2-Cre- females. Expected values according to
Mendelian frequencies are indicated in brackets. *Dead or resorbed embryos.
(B) Hoipfl/flTie2-Cre+ embryos died at E10.5 with vascular defects as shown macroscopically (i and ii) and microscopically by PECAM-1 staining (iii and iv).
Histology revealed defects in the heart such as enlargement of the pericardial cavity (black line) and thinning of the ventricular wall (arrow) (v and vi). See also
Figure S3B.
(C) Branching point quantification of images in (B) (iii and iv). Data are presented as mean ± SEM (n = 3 yolk sacs).
(D) Quantification of cell death shown in (E). Data are presented as mean ± SEM (n = 3 yolk sacs). AU, arbitrary units.
(E) Cell death analysis by whole-mount TUNEL staining showing gradual increase in cell death from E9.5 (i–iv) to E10.5 (v–viii). Images (iii) and (iv) and (vii) and (viii)
are magnifications of the indicated regions of the yolk sac.survived embryonic development had incomplete penetrance of
the Tie2-Cre-mediated deletion.
Like embryos with germline deletion ofHoip,Hoipfl/flTie2-Cre+
embryos appeared normal at early developmental stages up to
E9.5 (Figure S3B i and ii) but died at E10.5 with disrupted vascu-
larization, as observed macroscopically (Figures 3B i and ii) and
microscopically by PECAM-1 staining (Figures 3B iii and iv and
3C), and were resorbed at E11.5 (Figure S3B iii and iv). As a
consequence of decreased vascular density, Hoipfl/flTie2-Cre+
embryos also showed signs of cardiovascular failure with
enlargement of the pericardial space and thinning of the ventric-
ular wall (Figures 3B v and vi). Cell death analysis revealed pres-
ence of dying cells in yolk sacs of Hoipfl/flTie2-Cre+ embryos,
precisely as in Hoip/ embryos, with TUNEL-positive cells first
appearing at E9.5 (Figures 3D and 3E i–iv) and increasing sub-
stantially by E10.5 (Figures 3D and 3E v–viii). As withHoip/ em-
bryos, dead cells were also present in hearts ofHoipfl/flTie2-Cre+
embryos at E10.5 (Figure S3C).156 Cell Reports 9, 153–165, October 9, 2014 ª2014 The AuthorsAs the Tie2 promoter is known to be activated early during
embryogenesis (i.e., at E7.5) and thus before separation of the
endothelial from the immune cell lineage (Haar and Ackerman,
1971; Hamaguchi et al., 2006), we checked whether HOIP dele-
tion also occurred in immune cells of Hoipfl/flTie2-Cre+ embryos.
This was indeed the case, as confirmed by genotyping CD31+
(PECAM-1+) and CD45+ cells sorted from Cre+ and Cre em-
bryos (Figure S3D). In order to assess viability of immune cells
in Hoipfl/flTie2-Cre+ embryos, we analyzed the percentage of
living CD45+ cells by flow cytometry at E9.5 and E10.5 in whole
embryos, including yolk sacs. At E9.5, we observed no effect of
HOIP deficiency on immune cell viability (Figure S3E), while
death of endothelial cells in the yolk sacs of these embryos
was readily observed at this time (Figure 3D). At E10.5, however,
there is a reduction in the percentage of the immune cell popula-
tion. Therefore, although endothelial cell death appears to be the
first, and hence probably triggering, event in yolk sacs ofHoip/
embryos, immune cells are also affected.
Figure 4. Ablation of TNF Prolongs Survival by Preventing Endothelial Cell Death at Midgestation, but Not Late Gestation
(A) Representative images of Tnf/Hoip+/, Tnf/Hoip/, and Tnf+/Hoip/ embryos at different developmental stages. At E10.5, deletion of TNF recues the
lethality (i–iii). At E13.5, Tnf/Hoip/ embryos are alive but yolk sacs seemed poorly vascularized (iv and v). At E15.5, Tnf/Hoip/ embryos appear dead with
absent vascularization in yolk sacs (vi and vii).
(B) Cell death analysis by whole-mount TUNEL staining at E10.5 showing complete prevention of cell death upon TNF deletion.
(C) Quantification of cell death analysis shown in (B). Data are presented as mean ± SEM (n = 3 yolk sacs) AU, arbitrary units.
(D)Representative imagesof cleaved caspase-3 (green) andPECAM-1 (red) double staining in yolk sacs at E10.5 showingnocell death andnormal vascularization.
(E) Quantification of branching points as detected in the images in (D) (PECAM-1). Data are presented as mean ± SEM (n = 3 yolk sacs).
(F) Representative images of PECAM-1 staining of yolk sacs at different developmental stages (E13.5 and 15.5).
(G) Quantification of branching points as detected in the images in (F). Data are presented as mean ± SEM (n = 3 yolk sacs).TNF Deletion Prevents Cell Death at Midgestation and
Prolongs Survival of Hoip/ Embryos
Given that LUBAC is essential for regulating TNF-induced cell
death (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al.,
2011) and that TNF ablation prevented inflammation in cpdm
mice (Gerlach et al., 2011), we reasoned that TNF could alsocause endothelial cell death in Hoip/ embryos. If this were
the case, absence of TNF from Hoip/ embryos should over-
come lethality at E10.5. Indeed, genetic codeletion of Tnf in
Hoip/ mice rescued normal embryonic development and
vascularization at midgestation (Figures 4A i–iii, 4D, and 4E).
Whole-mount TUNEL and cleaved caspase-3 staining in yolkCell Reports 9, 153–165, October 9, 2014 ª2014 The Authors 157
Figure 5. Ablation of TNFR1 Rescues Cell Death at Late Gestation and Completely Prevents Vascularization Defects
(A) Cell death analysis as measured by propidium iodide (PI) incorporation and flow cytometry in Tnf/Hoip/ MEFs stimulated with TNF (100 ng/ml) or LT-a
(50 ng/ml) for 24 hr. Data are presented as mean ± SEM (n = 3 independent experiments).
(B) Representative images of Tnfr1/Hoip+/ and Tnfr1/Hoip/ embryos at different developmental stages. At E10.5, deletion of TNFR1 rescues the lethality
(i and ii). At E15.5, Tnfr1/Hoip/ embryos are alive and look properly vascularized (iii and iv). At E17.5, Tnfr1/Hoip/ embryos appear smaller, but the yolk
sac vascularization appears normal (v and vi). See also Figure S5A.
(C) Quantification of branching points as determined by PECAM-1 staining. Data are presented as mean ± SEM (n = 3 yolk sacs). See also Figure S5C.
(D) Representative images of cleaved caspase-3 (green) and PECAM-1 (red) staining of yolk sacs at E13.5 and E15.5 in Tnf/Hoip/ versus Tnfr1/Hoip/.
See also Figure S5D.
(legend continued on next page)
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sacs of Tnf/Hoip+/ versus Tnf/Hoip/ embryos at E10.5
showed a complete rescue from cell death in double mutants
(Figures 4B–4D). We therefore conclude that loss of vascular ar-
chitecture in Hoip/ embryos at E10.5 is due to TNF-mediated
endothelial cell death.
Despite rescuing Hoip/ embryos from lethality at midgesta-
tion, genetic ablation of Tnf did not result in Tnf/Hoip/ mice
being born (Figures S4A and S4B). Therefore, we studied
Tnf/Hoip/ embryos at different stages of development to
determine time and cause of death. Until E13.5, Tnf/Hoip/
embryos appeared normal, while their yolk sacs were already
less vascularized than those of control embryos (Figures 4A iv
and v). At E15.5, Tnf/Hoip/ embryos were dead and their
yolk sacs completely deprived ofmacroscopically visible vessels
(Figures 4A vi and vii). Analysis of the endothelial phenotype by
PECAM-1 staining revealed that at E13.5, Tnf/Hoip/ em-
bryos started losing vascular density (Figures 4F and 4G). This
was further aggravated at E15.5 (Figure 4F and G), when yolk
sacs were completely devoid of major vessels, both macro-
and microscopically (Figures 4A vii and 4F). The fact that we
could only detect vessels microscopically by PECAM-1 staining,
and not macroscopically, is likely due to deprivation of blood
supply as a consequence of endothelial cell death, which ren-
ders vessels undetectable macroscopically, whereas they
remain detectable by staining for specific endothelial cell
markers. Together, these results suggest that disruption of
vascular architecture, even if delayed, is also causative for em-
bryonic lethality at E15.5 in Tnf/Hoip/ embryos.
TNFR1, but Not TNF, Deletion Markedly Reduces Cell
Death and Restores Normal Vascularization
Apart from TNF, lymphotoxin-a (LT-a) also engageswith and sig-
nals through TNFR1 (Aggarwal et al., 1985). Indeed, we found
that murine embryonic fibroblasts (MEFs) obtained from
Tnf/Hoip/ embryos (we used Tnf/Hoip/ embryos to
facilitate generation of MEFs deficient in HOIP) were rendered
sensitive to death induction by both TNF and LT-a (Figure 5A),
in line with the recently reported finding that SHARPIN-deficient
cells are sensitized to TNF and LT-a (Etemadi et al., 2013). On
this basis we hypothesized that TNF deletion might be insuffi-
cient to fully correct the vascular defects because of an addi-
tional effect of LT-a on TNFR1. We therefore generated
Tnfr1/Hoip/ animals and, in accordance with our hypothe-
sis, Tnfr1/Hoip/ embryos underwent early embryogenesis
with normal vascularization and complete prevention of cell
death in the yolk sac (Figures 5B i and ii; Figure S5B). Impor-
tantly, Tnfr1/Hoip/ embryos survived past E15.5 (Figures
5B iii and vi). Yet, at E17.5, the incidence of living embryos was
not 100% (Figure S5A). Studying yolk sac vascularization at
various developmental stages up to the time of death revealed
that yolk sacs of Tnfr1/Hoip/ embryos appeared normally(E) Quantification of cleaved caspase-3 as detected in the images shown in (D);
Tnf/Hoip/ at E13.5, and n = 3 at E15.5; n = 4 for Tnfr1/Hoip+/ at E13.5 and
performed by ANOVA for multiple comparisons (#p < 0.001 Tnf/Hoip/ v
Tnfr1/Hoip/ at E15.5).
(F) Representative images of H&E staining on whole-embryo paraffin sections. A
(G) Representative images of TUNEL staining on heart sections at E15.5 embryovascularized throughout development, including at E13.5 and
E15.5 and in embryos still alive at E17.5 (Figure 5C; Figures
S5C and S5D). Thus, TNF and LT-a together are responsible
for the gradual loss of the vascular network up to late develop-
mental stages in Hoip/ embryos, yet in coabsence of their
common receptor, TNFR1, the vascular network is preserved.
Since this phenotype was different from that of Tnf/Hoip/
embryos, we compared the incidence of cell death in both em-
bryos before death. Whereas staining for cleaved caspase-3
showed reoccurrence of cell death at late gestation in
Tnf/Hoip/ embryos (Figures 5D and 5E), with cell death be-
ing higher at E13.5 than at E15.5 in Tnf/Hoip/ embryos,
consistent with the stage at which vascular density starts degen-
erating again (Figure 4G), in the Tnfr1/Hoip/ embryos, cell
death was markedly reduced at both developmental stages
and also at E17.5 (i.e., time of death) (Figures 5D and 5E; Fig-
ure S5D). Importantly, the significantly reduced, remaining level
of cell death (Figures 5D and E) did not disrupt normal vascular-
ization (Figure 5C; Figure S5C). Taken together, these results
show that TNFR1 deletion maintains integrity of the yolk sac
vascular network of Hoip/ embryos by preventing nonphysio-
logical endothelial cell death induced by TNF and LT-a.
While this result shows that inHoip/embryosTNFR1-depen-
dent aberrant cell death is responsible for disruption of yolk sac
vascular architecture, other cytokines could be responsible for
the remaining cell death observed in Tnfr1/Hoip/ embryos.
We therefore tested in vitro whether HOIP-deficient cells were
more sensitive to cytokines other than TNF and LT-a and found
that this was the case for CD95L, but not for interleukin-1b (IL-
1b) and IL-33 (Figure S5E). However, cell death induced by
CD95L in the absence of HOIP, as compared to control cells,
was not as pronounced as with TNF or LT-a (compare Figures
S5E and 5A). Thus, although the remaining cell death observed
at late gestation in yolk sacs of Tnfr1/Hoip/ embryos ap-
pears to bear no obvious functional consequences on vasculari-
zation (Figure 5C), CD95L could be responsible for this cell death.
Despite re-enabling proper yolk sac vascularization, TNFR1
ablation in Hoip/ animals could only further delay death during
embryogenesis until E17.5 and not until birth or thereafter. This
was surprising given that cIAP1/2-deficient mice are rescued
by TNFR1 coablation to birth (Moulin et al., 2012). It therefore ap-
pears that LUBAC plays a role in a cIAP1/2-independent
pathway that becomes vitally important at around E16.5/17.5
as revealed by the Tnfr1/Hoip/ embryos. To understand
the cause of their death, we analyzed themhistologically. This re-
vealed severe heart defects, with the atria and large blood ves-
sels of the heart highly dilated and full of blood (Figure 5F). Blood
vessels in other organs were also dilated suggesting cardiovas-
cular failure (Figure 5F). Interestingly, this phenotype is not
caused by excessive cell death in the heart (Figure 5G), indi-
cating that ablation of TNFR1 rescues cell death both in themean ± SEM (n = 4 yolk sacs for Tnf/Hoip+/ at E13.5 and E15.5, n = 5 for
E15.5, n = 3 for Tnfr1/Hoip/ at E13.5, and n = 9 at E15.5). Statistics were
ersus Tnfr1/Hoip/ at E13.5; cNS (nonsignificant) Tnf/Hoip/ versus
, atrium; V, ventricle; vessels are indicated by an arrow.
s with quantification. Data are presented as mean ± SEM (n = 3 embryos).
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yolk sac and in the heart. Importantly, this phenotype was
observed in mutants that were alive (i.e., showing heartbeat),
implying the heart defects as a cause, not consequence, of
death (Copp, 1995). Intriguingly, a proportion of double-mutant
embryos also showed neural tube closure defects of the anterior
brain at E10.5 resulting in exencephaly at late gestation
(Figure S5F).
Taken together, we show that TNFR1-mediated cell death is
causative for disruption of vascularization in HOIP-deficient em-
bryos. However, we also discover that when both HOIP and
TNFR1 are absent, morphological defects occur that appear to
be independent of cell death but caused by HOIP deficiency.
HOIP-Deficient Cells Fail to Properly Activate NF-kB/
MAPKs and Aberrantly Form the Cell-Death-Inducing
Complex-II
Having identified aberrant TNFR1-mediated signaling as causa-
tive for lethality at midgestation to late gestation due to HOIP
absence, we next assessed the molecular impact of HOIP defi-
ciency on TNFR1 signaling. We first tested whetherHoip/ cells
still generated linear linkages upon TNF stimulation. To do so, we
performed native TNF-RSC analysis as previously described
(Gerlach et al., 2011; Haas et al., 2009) from HOIP-deficient
versus HOIP-proficient MEFs stimulated with TNF for different
times. This revealed the presence of linear linkages in the TNF-
RSC in HOIP-proficient, but their complete absence from
HOIP-deficient, cells (Figure 6A). Thus, LUBAC is the only ubiq-
uitin E3 generating linear ubiquitin linkages in the TNF-RSC.
We next addressed how the absence of HOIP and, hence,
linear ubiquitin from the TNF-RSC affected signaling by TNF
and LT-a. We found that NF-kB and MAPK were activated less
strongly by both TNF and LT-a in HOIP-deficient MEFs
(Tnf/Hoip/) than in control MEFs (Tnf/Hoip+/) as
observed by delayed phosphorylation and degradation of IkBa
and phosphorylation of ERK (Figure 6B). In addition to decreased
gene-activatory signaling by the TNF-RSC, and consistent with
the increased sensitivity to TNF/LT-a-induced cell death (Fig-
ure 5A), we observed increased caspase-3 and caspase-8
cleavage (Figure 6B). As activation of these caspases is known
to result from complex-II, we examined whether formation of
this complex was aberrantly increased in cells devoid of HOIP
in response to TNF. Strikingly, whereas its formation was unde-
tectable in HOIP-proficient cells, complex-II was readily detect-
able in HOIP-deficient cells with robust recruitment of cleaved
caspase-8, RIP1, and RIP3 to FADD (Figure 6C). Thus, absence
of HOIP enables the premature and aberrant formation of the
cell-death-inducing complex-II of TNFR1 signaling.
Since this complex can mediate apoptotic and necroptotic
death (Green et al., 2011; Murphy and Silke, 2014) we next deter-
mined the type(s) of cell death induced in HOIP-deficient MEFs.
Treatment with the caspase inhibitor Q-Val-Asp(non-O-methyl-
ated)-OPh (QVD) or Necrostatin-1, an inhibitor of RIP1’s kinase
activity, partially blocked TNF-induced death in HOIP-deficient
MEFs, which was further reduced by the combination thereof
(Figure 6D). Taken together, these results show that deletion of
HOIP on the one hand attenuates but does not prevent
TNFR1-mediated gene activation and on the other hand mark-
edly increases formation of complex-II, consequently enabling160 Cell Reports 9, 153–165, October 9, 2014 ª2014 The Authorsthe induction of aberrant cell death upon stimulation by either
of its ligands, TNF or LT-a.
HOIP’s Catalytic Activity Is Required for Protection from
TNF-Induced Cell Death
We finally aimed to determine whether HOIP’s catalytic activity is
required for protecting cells from TNF-induced death or whether
the presence of HOIP, and thus of LUBAC, as a mere scaffold in
the TNF-RSC rather than an enzymatically active component
is responsible for this effect. To do so, we reconstituted
Tnf/Hoip/MEFs with wild-type (WT) or catalytically inactive
(C885S) HOIP. While reconstitution with both forms of HOIP
restored expression of HOIL-1 and SHARPIN (Figure 7A), recon-
stitution with HOIP (C885S) failed to rescue TNF-induced activa-
tion of NF-kB and MAPK to normal levels (Figure 7B) and,
importantly, also failed to prevent TNF-induced cell death, con-
trary to reconstitution with WT HOIP (Figure 7C). These results
show that HOIP’s catalytic activity is required for proper
signaling output of the TNF-RSC.
DISCUSSION
Here, we show that constitutive deficiency in the enzymatically
active component of LUBAC, HOIP, results in embryonic
lethality at midgestation due to disruption of vascularization in
the yolk sac and consequent cardiovascular failure. Specific
deletion of Hoip from endothelial and immune precursor cells
with Tie2-promoter-driven Cre resulted in the same phenotype
as constitutive deletion of Hoip. Both constitutive and endothe-
lial/immune-specific deletion of Hoip resulted in a substantial
increase in death of endothelial cells in the yolk sac at midges-
tation, which is causative for disrupted vascularization and,
consequently, death. Given that early hematopoiesis takes
place in the yolk sac (Inlay et al., 2014), it is difficult to ascertain
whether the absence of HOIP from immune cells exerts a direct
effect on them or whether the percentage reduction is due to
the yolk sac itself degenerating as a consequence of endothe-
lial cell death. However, although an effect of HOIP deficiency
on immune cells cannot be formally excluded, given the sub-
stantial death of endothelial cells we observe in the yolk sacs
of both HOIP-deficient and Hoipfl/flTie2-Cre+ embryos, which,
importantly, occurs prior to reduction in viability of immune
cells, we propose death of endothelial, and not immune, cells
as the primary cause of embryonic lethality in Hoip/ and
Hoipfl/flTie2-Cre+ embryos. The fact that endothelial rather
than other cells die in the embryo may be due to differential
exposure to TNF and LT-a, which are known to play important
roles in secondary lymphoid organ development. Alternatively,
endothelial cells may be particularly dependent on HOIP for
survival.
Genetic deletion of either TNF or TNFR1 in HOIP-deficient
mice prevented cell death in yolk sacs, restored normal vascular-
ization, and, crucially, rescued these embryos from death at
E10.5. This implies that endothelial cell death causes disruption
of the vascular network and argues against the possibility that
HOIP deficiency leads to a defect in developmental pathways,
such as angiogenesis. If this were the case, genetic coablation
of TNF or TNFR1 would not suppress lethality at midgestation
Figure 6. HOIP Is Required for Optimal NF-kB/MAPK Activation and Prevention of Complex-II Formation in Response to TNF
(A) Endogenous TNF-RSC pull-down was performed by TNF immunoprecipitation (IP) in HOIP-proficient and HOIP-deficient cells upon different times of TNF
stimulation. Western blot analysis was performed to identify linear ubiquitin chains or the indicated proteins recruited to the complex. TCL, total cellular lysate.
(B) Western blot analysis of the indicated proteins in whole-cell lysates from MEFs following TNF (100 ng/ml) or LT-a (100 ng/ml) stimulation for different time
points (min).
(C) FADD immunoprecipitation (IP) was performed in immortalized MEFs treated for 4 hr with 20 mM zVAD-fmk in the presence or absence of TNF (100 ng/ml) for
4 hr. Total cellular lysates (TCL) and IP were analyzed by western blot for the indicated proteins.
(D) Cell death was analyzed by propidium iodide (PI) incorporation in MEFs stimulated with TNF (100 ng/ml) for 24 hr plus the indicated cell death inhibitors. Data
are presented as mean ± SEM (n = 3 independent experiments).
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Figure 7. Catalytic Activity of HOIP Is Required for Optimal NF-kB/MAPK Activation and for Protection against Cell Death upon TNF Stim-
ulation
(A) Western blot analysis of the LUBAC components in whole-cell lysates fromMEFs reconstituted with wild-type HOIP (WT), catalytically inactive HOIP (C885S),
or empty vector.
(B) Western blot analysis of the indicated proteins in whole-cell lysates from Tnf/Hoip/MEFs reconstituted with the indicated forms of HOIP following TNF
(100 ng/ml) stimulation for different time points (min).
(C) PI incorporation in MEFs reconstituted with the indicated forms of HOIP and stimulated with TNF (100 ng/ml). Data are presented as mean ± SEM (n = 3
independent experiments).in HOIP-deficient embryos. Furthermore, cell death became
apparent again in the yolk sac vasculature of Tnf/Hoip/ em-
bryos at E15.5, which coincided with failure of vascularization at
this stage. Thus, defective vasculature always occurs together
with, andmost likely as a consequence of, endothelial cell death.
Supporting this notion, cell death in the yolk sac endothelium of
Tnfr1/Hoip/was very low, and the vasculature of thesemice
was unaffected.
Although LT-a was the first TNF superfamily member to be
cloned (Gray et al., 1984) and, like TNF, signals via TNFR1 (Ete-
madi et al., 2013), TNF is the predominant ligand that drives
TNFR1 signaling in vivo, as loss of TNF and TNFR1 phenocopy
each other for most functions analyzed so far (Marino et al.,
1997; Pasparakis et al., 1996; Rothe et al., 1993). By contrast,
deletion of LT-a most closely phenocopies loss of LT-b and
LT-bR, since LT-a is required to form heterotrimeric LTa1LTb2
(Browning et al., 1993; Crowe et al., 1994). It is therefore note-
worthy that in the pathological scenario of Hoip depletion, loss
of TNF does not phenocopy loss of TNFR1, indicating a physio-
logical role for the LTa3/TNFR1 signaling.
Histological analysis of Tnfr1/Hoip/ embryos at E15.5 re-
vealed severe morphological defects in the heart, which appear
to be independent of cell death. In addition, a proportion of these
embryos also exhibited exencephaly. Interestingly, abnormal-
ities in neural crest induction or delamination have previously
been shown to account for this particular combination of pheno-
types (Barbera et al., 2002), and these abnormalities could there-
fore also be causative for them in Tnfr1/Hoip/ embryos. It is
currently unclear, however, which cell-death-independent
pathway is perturbed by absence of HOIP to result in these de-
fects. A mutation in OTULIN, a deubiquitinase that specifically
dismantles linear ubiquitin chains, causes embryonic lethality
between E12.5 and 14.5. The authors showed that these em-162 Cell Reports 9, 153–165, October 9, 2014 ª2014 The Authorsbryos suffered from deficits in the cranial vasculature and sug-
gested a role for OTULIN in canonical Wnt signaling during
angiogenesis (Rivkin et al., 2013). Although we determined the
vascular defects inHoip/ embryos to be due to aberrant endo-
thelial cell death rather than defective angiogenesis,
Tnfr1/Hoip/ embryos had dramatic defects in the heart,
most likely caused by aberrant neural crest induction. It is
tempting to speculate that proper Wnt signaling, known to be
required for various developmental processes during embryo-
genesis (Copp, 1995; van Amerongen and Berns, 2006), could
be perturbed in HOIP’s absence and thereby responsible for
the phenotype of Tnfr1/Hoip/ embryos.
Reconstitution experiments performed in this study show
that not only the physical presence of HOIP and LUBAC
but also its catalytic activity in the TNF-RSC is required to pre-
vent TNF-induced cell death. This result is in accordance
with the recent mentioning of HOIP’s catalytic activity as
essential for embryogenesis (Emmerich et al., 2013). Together,
this shows that LUBAC and its linear-ubiquitin-forming activ-
ity are required to inhibit TNF-induced death for proper
embryogenesis.
LUBAC forms part of the TNF-RSC and contributes to full NF-
kB activation. However, the findings we report here, in conjunc-
tion with the reported phenotypes of mice devoid of individual
components of the TNF-triggered gene-activatory and cell death
pathways, respectively, allow us to deduce that it is indeed the
lack of proper control of cell death, importantly independently
of the gene-activatory role of LUBAC, which is responsible for
lethality of HOIP deficiency. The rationale for this conclusion is
laid out in the next paragraph.
Indeed, we observed attenuated gene-activatory signaling in
TNF- and LT-a-stimulated Tnf/Hoip/ MEFs, confirming a
role for LUBAC in maintaining optimal NF-kB activation by the
TNF-RSC. Yet, while NF-kB activation was only reduced, there
was a robust formation of complex-II in HOIP-deficient cells
upon TNF stimulation, which did not occur in HOIP-proficient
cells. It therefore appears that aberrant complex-II formation
is responsible for nonphysiological TNFR1-mediated death of
endothelial cells in the yolk sac and, consequently, embryonic
lethality of HOIP deficiency at midgestation. However, this
alone would be insufficient to conclude that attenuated NF-
kB-mediated gene activation would not play a role in rendering
cells more TNF sensitive in the absence of HOIP. Yet, if atten-
uated NF-kB activation were responsible, then mice with a
complete lack in NF-kB activation should die at least as early
as HOIP-deficient mice. This is, however, not the case. Instead,
IKKa-deficient mice die perinatally (Takeda et al., 1999), and
IKKb and NEMO/IKKg deficiency results in embryonic lethality
at late gestation (E12.5/14.5), yet from liver injury (Rudolph
et al., 2000; Schmidt-Supprian et al., 2000; Tanaka et al.,
1999), hence a phenotype very different from the one we
observed in Hoip/ embryos. On the contrary, deficiency in
components of the cell death complex, such as caspase-8,
FADD, and FLIP, results in embryonic lethality at midgestation,
precisely at E10.5 (Varfolomeev et al., 1998; Yeh et al., 1998,
2000; Zhang et al., 1998), which, intriguingly, is also when cas-
pase-8 was specifically deleted in endothelial cells (Kang et al.,
2004). Importantly, these deaths at midgestation were recently
revealed to be due to aberrant necroptotic and/or apoptotic cell
death, depending on which component was deleted (Dillon
et al., 2012; Kaiser et al., 2011; Oberst et al., 2011; Zhang
et al., 2011).
Together, our findings indicate that LUBAC-dependent cell
death regulation is crucial for proper vascularization during mid-
stages of embryogenesis and that the phenotype of HOIP-defi-
cient embryos mimics the ones observed in the absence of
cell-death-associated components. It will be interesting to
assess the effect of interferencewith apoptosis and/or necropto-
sis by their concomitant genetic coinactivation (Dillon et al.,
2012; Kaiser et al., 2011). However, this analysis cannot realisti-
cally be achieved by conventional breeding strategies, since the
genes encoding HOIP and RIP3 are located within 200 kbp of
each other on chromosome 14 in mice.
In summary, we propose that due to lack of linear ubiquitina-
tion, the balance between TNF-induced gene activation and
cell death is disturbed in HOIP-deficient embryos in favor of
cell death and that the nonphysiological cell death resulting
from this disbalance is responsible for the lethality caused by
HOIP deficiency at midgestation.EXPERIMENTAL PROCEDURES
Mice
The HOIP-deficient mouse strain used for this study was created from embry-
onic stem cell clone EPD0161_5_A05 obtained from KOMP Repository (http://
www.komp.org) and generated by the Wellcome Trust Sanger Institute.
Methods used on the targeted alleles have been previously described
(Skarnes et al., 2011). The targeting cassette was composed of a lacZ reporter
gene plus a neomycin cassette flanked by Frt sites and exons 6
(ENSMUSE00000316844) to 11 (ENSMUSE00000316820) of the hoip gene
flanked by loxP sites. The mice were generated via C57BL/6N ES cell micro-
injection into BALB/c blastocysts to generate chimeric mice, which werebred for germline transmission through the ES Cell to Mouse service of the
Australian Phenomics Network. The chimeric progeny were bred to generate
HOIP-floxed animals. The neomycin cassette was removed by crossing these
micewithmice expressing the frt-deleter FlpE recombinase (C57BL/6J) (Farley
et al., 2000) to remove the reporter gene. Subsequently, the progeny was
crossed with transgenic mice expressing the loxP-deleter Cre recombinase
purchased from JAX (6054, B6.C-Tg[CMV-Cre]1 Cgn/J) to generate full-
knockout animals. Alternatively, transgenic mice expressing the Cre recombi-
nase under the control of the Tie2 promoter (Tie2-Cre) (B6.Cg-Tg[Tek-cre]
1Ywa/J) (Gustafsson et al., 2001) were crossed with HOIP-floxed animals to
delete HOIP specifically in endothelial cells. Tnf/ mice were a gift from Wil-
liam Kaiser (B6;129S6), and Tnfr1/ mice were purchased from JAX (2818,
B6.129-Tnfrsf1atm1Mak/J). All mice were crossed for at least five generations
before the embryological studies. All mice were typed by PCR analysis. Col-
onies were fed ad libitum and kept under an appropriate UK project license.
Timed Matings, Histological Analysis, and In Situ Hybridization
A single male was paired with one or two females, which were plug checked
daily. The embryonic days were counted starting E0.5 on the day the vaginal
plug was detected. The embryos were taken from the mothers at different
developmental stages, fixed in 4% paraformaldehyde for 24 hr, refrigerated,
and stored inmethanol for further analysis. For histological purposes, embryos
were paraffin embedded, and serial sections of 4 mm were performed. Sec-
tions were stained with hematoxylin and eosin (H&E). Eight sagittal serial sec-
tions of two different planes of the embryo were analyzed by a pathologist. In
situ hybridization of whole-mount embryos was performed by standard proce-
dures (Behringer, 2003). The probe was generated by cloning a 1.3 kb region of
Hoip cDNA in pcDNA3 vector. Sense and antisense probes were generated by
in vitro transcription using digoxigenin-labeled dinucleotide triphosphates and
SP6 and T7 promoters, respectively.
Statistical Analysis
Statistical significance was determined using unpaired Student’s t test. A p
value < 0.05 was considered significant and indicated with *p < 0.05, **p <
0.01, and ***p < 0.001. Alternatively, whenever stated, ANOVA for multiple
comparisons was used.
SUPPLEMENTAL INFORMATION
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and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.08.066.
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